SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001104659-12-017926
Filing Date
2012-03-13
Accepted
2012-03-13 17:04:05
Documents
1
Period of Report
2012-03-09
Filing Date Changed
2012-03-13

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4026
  Complete submission text file 0001104659-12-017926.txt   5469
Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353-1-634-4183
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O BEECKEN PETTY O'KEEFE & COMPANY 131 S. DEARBORN STREET, SUITE 2800 CHICAGO IL 60603
Business Address
O'Keefe Kenneth W (Reporting) CIK: 0001397661 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 12687763